The DOI matches its Crossref record; 145 of the 145 references it cites were found in a registry or an index.
Diabetes and Hypertension: A Position Statement by the American Diabetes Association
Open accessAbstract
Hypertension is common among patients with diabetes, with the prevalence depending on type and duration of diabetes, age, sex, race/ethnicity, BMI, history of glycemic control, and the presence of kidney disease, among other factors (1-3).Furthermore, hypertension is a strong risk factor for atherosclerotic cardiovascular disease (ASCVD), heart failure, and microvascular complications.ASCVDddefined as acute coronary syndrome, myocardial infarction (MI), angina, coronary or other arterial revascularization, stroke, transient ischemic attack, or peripheral arterial disease presumed to be of atherosclerotic origindis the leading cause of morbidity and mortality for individuals with diabetes and is the largest contributor to the direct and indirect costs of diabetes.Numerous studies have shown that antihypertensive therapy reduces ASCVD events, heart failure, and microvascular complications in people with diabetes (4-8).Large benefits are seen when multiple risk factors are addressed simultaneously (9).There is evidence that ASCVD morbidity and mortality have decreased for people with diabetes since 1990 (10,11) likely due in large part to improvements in blood pressure control (12-14).This Position Statement is intended to update the assessment and treatment of hypertension among people with diabetes, including advances in care since the American Diabetes Association (ADA) last published a Position Statement on this topic in 2003 (3). DEFINITIONS, SCREENING, AND DIAGNOSISRecommendations c Blood pressure should be measured at every routine clinical care visit.Patients found to have an elevated blood pressure ($140/90 mmHg) should have blood pressure confirmed using multiple readings, including measurements on a separate day, to diagnose hypertension.B c All hypertensive patients with diabetes should have home blood pressure monitored to identify white-coat hypertension.B c Orthostatic measurement of blood pressure should be performed during initial evaluation of hypertension and periodically at follow-up, or when symptoms of orthostatic hypotension are present, and regularly if orthostatic hypotension has been diagnosed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“There is strong evidence from clinical trials of the value of treating hypertension in older adults (70,71), with treatment of hypertension to individualized target levels indicated in most.”
From 13. Older Adults: Standards of Care in Diabetes—2024 (2024) · cites this paper as [71]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“There is strong evidence from clinical trials of the value of treating hypertension in older adults (72,73), with treatment of hypertension to individualized target levels indicated in most.”
From 13. Older Adults: Standards of Care in Diabetes—2025 (2025) · cites this paper as [73]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“There is strong evidence from clinical trials of the value of treating hypertension in older adults”
From 13. Older Adults: Standards of Care in Diabetes—2026 (2026) · cites this paper as [80]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Antihypertensive therapy reduces the risk of albuminuria (67)(68)(69)(70), and among people with type 1 or 2 diabetes with established CKD (eGFR <60 mL/min/1.73m 2 and UACR $300 mg/g creatinine), ACE inhibitor or ARB therapy reduces the risk of progression to ESKD (71)(72)(73)(74)(75)(76)(77)(78)(79)(80).”
From 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [70]
The cited source says what the claim attributes to it.
In the citing paper
“For individuals with albuminuria (urine albumin-to-creatinine ratio [UACR] $30 mg/g), initial treatment should include an ACE inhibitor or ARB to reduce the risk of progressive kidney disease (21) (Fig. 10.2).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [21]
In the citing paper
“For patients with albuminuria (urine albumin-to-creatinine ratio [UACR] $ 30 mg/g), initial treatment should include an ACE inhibitor or ARB to reduce the risk of progressive kidney disease (20) ( Fig. 10.2 ).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 (2023) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
James, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennison-Himmelfarb, C., Handler, J., Lackland, D. T., LeFevre, M. L., MacKenzie, T. D., Ogedegbe, O., et al. (2014) · JAMA · doi:10.1001/jama.2013.284427 · Cited by 7,950
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
The SPRINT Research Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1511939 · Cited by 6,325
Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
Hansson, L., Zanchetti, A., Carruthers, S. G., Dahlöf, B., Elmfeldt, D., Julius, S., Ménard, J., Rahn, K. H., Wedel, H., & Westerling, S. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04311-6 · Cited by 5,728
Sacks, F. M., Svetkey, L. P., Vollmer, W. M., Appel, L. J., Bray, G. A., Harsha, D., Obarzanek, E., Conlin, P. R., Miller, E. R., Simons-Morton, D. G., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101043440101 · Cited by 5,638
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
Lewis, E. J., Hunsicker, L. G., Bain, R. P., & Rohde, R. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311113292004 · Cited by 5,394
Flagged first, then by citations
Research works printed but not linked: 1
- Lin JS, O’Connor EA, Evans CV, Senger CA, Rowland MG, Groom HC. Behavioral Counseling to Promote a Healthy Lifestyle for Cardiovascular Disease Prevention in Persons With Cardiovascular Risk Factors: An Updated Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet], 2014. Rockville, MD, Agency for Healthcare Research and Quality (US), 2014. Available from http://www.ncbi.nlm.nih.gov/books/NBK241537/. Accessed 11 November 2016
Cited by
Sorted by citations
Items 101–200 of 714
Salts and Cocrystal of Etodolac: Advantage of Solubility, Dissolution, and Permeability
Rai, S. K., Allu, S., & Nangia, A. K. (2020) · Crystal Growth & Design · doi:10.1021/acs.cgd.0c00313 · Cited by 49
Or, C. K., Holden, R. J., & Valdez, R. S. (2022) · Automation, collaboration, and e-services · doi:10.1007/978-3-031-10788-7_6 · Cited by 50
Blood Pressure Variability and Risk of Heart Failure in ACCORD and the VADT
Nuyujukian, D. S., Koška, J., Bahn, G., Reaven, P. D., Zhou, J. J., & VADT Investigators (2020) · Diabetes Care · doi:10.2337/dc19-2540 · Cited by 46
Zhang, M., Yang, X., Ren, M., Sui, M., Dhakal, R., Kim, N., Li, Y., & Yao, Z. (2022) · Scientific Reports · doi:10.1038/s41598-022-20285-6 · Cited by 45
Hu, M., Cai, X., Yang, W., Zhang, S., Nie, L., & Ji, L. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.015323 · Cited by 46
Brouwer, T. F., Vehmeijer, J. T., Kalkman, D. N., Berger, W. R., van den Born, B.-J. H., Peters, R. J., & Knops, R. E. (2018) · Diabetes Care · doi:10.2337/dc17-1722 · Cited by 44
Buckley, L. F., Dixon, D. L., Wohlford, G. F., Wijesinghe, D. S., Baker, W. L., & Van Tassell, B. W. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13248 · Cited by 42
Precision Medicine for Hypertension Patients with Type 2 Diabetes via Reinforcement Learning
Oh, S. H., Lee, S. J., & Park, J. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12010087 · Cited by 41
RSSDI Guidelines for the management of hypertension in patients with diabetes mellitus
Kumar, V., Agarwal, S., Saboo, B., & Makkar, B. M. (2022) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-022-01143-7 · Cited by 47
Koye, D. N., Ling, J. Z. J., Dibato, J. E., Khunti, K., Montvida, O., & Paul, S. K. (2020) · Diabetes Care · doi:10.2337/dc20-0417 · Cited by 43
Wu, Y., Hu, H., Cai, J., Chen, R., Zuo, X., Cheng, H. W., & Yan, D. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00747-0 · Cited by 43
Saglimbene, V., Palmer, S. C., Ruospo, M., Natale, P., Maione, A., Nicolucci, A., Vecchio, M., Tognoni, G., Craig, J. C., Pellegrini, F., et al. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2018040443 · Cited by 39
Type 2 Diabetes and Thiazide Diuretics
Scheen, A. J. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-0976-6 · Cited by 39
Cardiovascular disease in type 1 diabetes
Sharma, H. C., Lencioni, M., & Narendran, P. (2019) · Cardiovascular Endocrinology & Metabolism · doi:10.1097/xce.0000000000000167 · Cited by 41
Brazilian Guidelines of Hypertension – 2025
Brandão, A. A., Rodrigues, C. I. S., Bortolotto, L. A., Armstrong, A. D. C., Mulinari, R. A., Feitosa, A. D. M., Gomes, M. A. M., Barbosa, E. C. D., Moura-Neto, J. A., Neves, M. F., et al. (2025) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20250624 · Cited by 102
Asbaghi, O., Naeini, F., Ashtary‐Larky, D., Kaviani, M., Kelishadi, M. R., Eslampour, E., Moradi, S., Mirzadeh, E., Clark, C. C. T., & Naeini, A. A. (2021) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2021.102755 · Cited by 41
Jiang, Y., Li, Y., Shi, K., Wang, J., Qian, W.-L., Yan, W.-F., Pang, T., & Yang, Z.-G. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01438-9 · Cited by 31
Raber, I., Belanger, M. J., Farahmand, R., Aggarwal, R., Chiu, N., Rifai, M. A., Jacobsen, A. P., Lipsitz, L. A., & Juraschek, S. P. (2022) · Hypertension · doi:10.1161/hypertensionaha.122.18557 · Cited by 41
Shaka, H., Aguilera, M., Aucar, M. E. L., El‐amir, Z., Wani, F., Muojieje, C. C., & Kichloo, A. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab372 · Cited by 37
Kinguchi, S., Wakui, H., Ito, Y., Kondo, Y., Azushima, K., Osada, U. N., Yamakawa, T., Iwamoto, T., Yutoh, J., Misumi, T., et al. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0912-3 · Cited by 36
KDOQI US Commentary on the 2017 ACC/AHA Hypertension Guideline
Kramer, H., Townsend, R. R., Griffin, K. A., Flynn, J. T., Weiner, D. E., Rocco, M. V., Choi, M. J., Weir, M. R., Chang, T. I., Agarwal, R., et al. (2019) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2019.01.007 · Cited by 37
Sheleme, T., Mamo, G., Melaku, T., & Sahilu, T. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s281992 · Cited by 41
Rosland, A.-M. M., Piette, J. D., TRIVEDI, R. B., Lee, A. A., STOLL, S. C., Youk, A. O., Obrosky, D. S., Deverts, D. J., Kerr, E. A., & Heisler, M. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.37960 · Cited by 38
Achila, O. O., Ghebretinsae, M., Kidane, A., Simon, M., Makonen, S., & Rezene, Y. (2020) · Journal of Diabetes Research · doi:10.1155/2020/5901569 · Cited by 34
Lisco, G., Tullio, A. D., Giagulli, V. A., Guastamacchia, E., Pergola, G. D., & Triggiani, V. (2020) · Endocrine · doi:10.1007/s12020-020-02444-9 · Cited by 37
Tola, A., Regassa, L. D., & Ayele, Y. (2021) · SAGE Open Medicine · doi:10.1177/2050312120987385 · Cited by 34
Cantley, N. W. P., Lonnen, K., Kyrou, I., Tahrani, A. A., & Kahal, H. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00851-1 · Cited by 34
Islam, N. S., Wyatt, L. C., Ali, S. H., Zanowiak, J. M., Mohaimin, S., Goldfeld, K. S., LOPEZ, P. M., Kumar, R., Beane, S. J., Thorpe, L. E., et al. (2023) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.122.009321 · Cited by 40
Wang, J., Gao, Y., Wang, F., Zeng, S., Li, J., Miao, H., Wang, T., Zeng, J., Baptista‐Hon, D. T., Monteiro, O., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2308812120 · Cited by 38
Russell, A. W., Donald, M., Borg, S. J., Zhang, J., Burridge, L. H., Ware, R. S., Begum, N., McIntyre, D. H., & Jackson, C. L. (2018) · Diabetologia · doi:10.1007/s00125-018-4740-x · Cited by 33
Holman, N., Knighton, P., OʼKeefe, J., Wild, S. H., Brewster, S., Price, H. C., Patel, K., Hanif, W., Patel, V., Gregg, E. W., et al. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14528 · Cited by 33
Tu, Q., Xiao, L. D., Ullah, S., Fuller, J. D., & Du, H. (2020) · Journal of Advanced Nursing · doi:10.1111/jan.14466 · Cited by 33
Verma, I., Gopaldasani, V., Jain, V., Chauhan, S., Chawla, R., Verma, P. K., & Hosseinzadeh, H. (2022) · Primary care diabetes · doi:10.1016/j.pcd.2022.10.007 · Cited by 33
Yaribeygi, H., Farrokhi, F. R., Abdalla, M. A., Sathyapalan, T., Banach, M., Jamialahmadi, T., & Sahebkar, A. (2021) · Journal of Diabetes Research · doi:10.1155/2021/6518221 · Cited by 31
Are All Patients With Type 1 Diabetes Destined for Dialysis if They Live Long Enough? Probably Not
Bakris, G. L., & Molitch, M. E. (2018) · Diabetes Care · doi:10.2337/dci17-0047 · Cited by 31
Self-citationLakshmanan, A. P., Shatat, I. F., Zaidan, S. A., Jacob, S. S., Bangarusamy, D. K., Alabduljabbar, S., Al‐Khalaf, F., Petroviski, G., & Terranegra, A. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111736 · Cited by 31
Broni, E. K., Ndumele, C. E., Echouffo-Tcheugui, J. B., Kalyani, R. R., Bennett, W. L., & Michos, E. D. (2022) · Current Diabetes Reports · doi:10.1007/s11892-021-01444-x · Cited by 32
Self-citationWan, E. Y. F., Yu, E. Y. T., Chin, W. Y., Fung, C. S. C., Fong, D., Choi, E. P. H., Chan, A. K. C., & Lam, C. L. K. (2018) · Diabetes Care · doi:10.2337/dc17-2443 · Cited by 30
Al‐Azzam, N. Z., Al-Azzam, S. I., Elsalem, L., & Karasneh, R. A. (2020) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2020.12.038 · Cited by 30
Heimark, S., Mehlum, M. H., Mancia, G., Søraas, C. L., Liestøl, K., Wachtell, K., Larstorp, A. C. K., Rostrup, M., Mariampillai, J. E., Kjeldsen, S. E., et al. (2023) · Hypertension · doi:10.1161/hypertensionaha.123.21454 · Cited by 30
Portable liquid chromatography for point-of-care testing of glycated haemoglobin
Ding, L., Chen, H., Ren, S., Zhang, Y., Yang, Y., & Chang, H. (2019) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2019.127484 · Cited by 29
Choi, J. S. Y., de Haan, J. B., & Sharma, A. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15591 · Cited by 29
Gilani, A., Juraschek, S. P., Belanger, M. J., Vowles, J., & Wannamethee, S. G. (2021) · BMJ · doi:10.1136/bmj.n922 · Cited by 28
Yang, Y., Miao, C., Wang, Y., He, J., & Bo, Y. (2024) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3830 · Cited by 29
Regular swimming exercise improves metabolic syndrome risk factors: a quasi-experimental study
Omar, J. S., Jaradat, N. A., Qadoumi, M., & Qadoumi, A. N. (2021) · BMC Sports Science Medicine and Rehabilitation · doi:10.1186/s13102-021-00254-8 · Cited by 27
Kasar, K. S., Aşiret, G. D., Yılmaz, C. K., & Canlar, Ş. (2021) · Primary care diabetes · doi:10.1016/j.pcd.2021.09.005 · Cited by 29
Lin, B., Ma, Y., & Jun-wei, W. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.870049 · Cited by 29
Prevalence of prediabetes and diabetes among older adults in Ecuador: Analysis of the SABE survey
Orces, C. H., & Lorenzo, C. (2017) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2017.12.002 · Cited by 27
Peralta, F. G., & Abreu, C. (2019) · Drug Design Development and Therapy · doi:10.2147/dddt.s165372 · Cited by 30
Dietary Sodium Intake and Risk of Incident Type 2 Diabetes
Wang, X., Ma, H., Kou, M., Tang, R., Xue, Q., Li, X., Harlan, T. S., Heianza, Y., & Qi, L. (2023) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2023.02.029 · Cited by 26
Tian, J., Sheng, C., Sun, W., Song, X., Wang, H., Li, Q., Li, W., & Wang, W. (2018) · Diabetes Care · doi:10.2337/dc18-0918 · Cited by 25
Hu, X., & Zhang, L. (2022) · Antioxidants · doi:10.3390/antiox11122432 · Cited by 22
Cardiometabolic medicine – the US perspective on a new subspecialty
Reiter–Brennan, C., Cainzos‐Achirica, M., Soroosh, G., Saxon, D. R., Blaha, M. J., & Eckel, R. H. (2020) · Cardiovascular Endocrinology & Metabolism · doi:10.1097/xce.0000000000000224 · Cited by 26
Diabetes and Hypertension: Clinical Update
Khangura, D., Kurukulasuriya, L. R., Whaley‐Connell, A. T., & Sowers, J. R. (2018) · American Journal of Hypertension · doi:10.1093/ajh/hpy025 · Cited by 25
Kim, B., Kim, H.-S., Park, S., Park, C. G., Seung, K. B., Gwon, H., Choi, D., Ahn, T. H., Kim, C. J., Kwon, H. M., et al. (2021) · Hypertension Research · doi:10.1038/s41440-021-00683-5 · Cited by 24
Dey, S., Mukherjee, A., Pati, M. K., Kar, A., Ramanaik, S., Pujar, A., Malve, V., Mohan, H. L., Jayanna, K., & Swaroop, N. (2022) · Archives of Public Health · doi:10.1186/s13690-022-00996-y · Cited by 31
Control of blood pressure and cardiovascular outcomes in type 2 diabetes
Vargas‐Uricoechea, H., & Cáceres-Acosta, M. F. (2018) · Open Medicine · doi:10.1515/med-2018-0048 · Cited by 23
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension
Steffen, H., Bönner, G., & Middeke, M. (2021) · New England Journal of Medicine · doi:10.1056/nejmc2117463 · Cited by 24
Hypertension and cardiovascular disease in the sub-Saharan African context
Seedat, Y. K., Ali, A., & Ferdinand, K. C. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.06.45 · Cited by 23
Evaluation of Vitamin D Levels in Patients With Diabetic Foot Ulcers
Tsitsou, S., Dimosthenopoulos, C., Eleftheriadou, I., Andrianesis, V., & Tentolouris, N. (2021) · The International Journal of Lower Extremity Wounds · doi:10.1177/1534734620984584 · Cited by 25
Vancampfort, D., Schuch, F. B., Damme, T. V., Firth, J., Suetani, S., Stubbs, B., & Biesen, D. V. (2021) · Journal of Applied Research in Intellectual Disabilities · doi:10.1111/jar.12949 · Cited by 23
Analysis of Antidiabetic Activity of Squalene via In Silico and In Vivo Assay
Widyawati, T., Syahputra, R. A., Syarifah, S., & Sumantri, I. B. (2023) · Molecules · doi:10.3390/molecules28093783 · Cited by 23
Shah, M. K., Wyatt, L. C., Gibbs-Tewary, C., Zanowiak, J. M., Mammen, S., & Islam, N. S. (2023) · Journal of General Internal Medicine · doi:10.1007/s11606-023-08443-6 · Cited by 22
Jasmine, A., Venguidesvarane, A. G., Durai, V., Anitha Rani, M., Shriraam, V., Samya, V., Gayathri, T., & Mahadevan, S. (2020) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-020-00885-6 · Cited by 29
Elsayed, A. M., Ahmed, A. M., & Aly, A. H. (2022) · Applied Optics · doi:10.1364/ao.443621 · Cited by 22
Chai, T., Wong, C. C.-C., Sabri, M. Z., & Wong, F. (2022) · Molecules · doi:10.3390/molecules27123864 · Cited by 22
dʼEmden, M. C., Amerena, J. V., Deed, G., Pollock, C. A., & Cooper, M. E. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.11.023 · Cited by 22
The Italian Society of Hypertension and Federfarma, Feo, M. D., Pinto, R. D., Pagliacci, S., Grassi, D., & Ferri, C. (2021) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-021-00449-7 · Cited by 22
Lascar, N., Altaf, Q., Raymond, N. T., Brown, J. E. P., Pattison, H. M., Barnett, A. H., Bailey, C. J., & Bellary, S. (2019) · Current Medical Research and Opinion · doi:10.1080/03007995.2019.1638239 · Cited by 22
Dixon, D. L., Baker, W. L., Buckley, L. F., Salgado, T. M., Tassell, B. W. V., & Carter, B. L. (2021) · Hypertension · doi:10.1161/hypertensionaha.121.17873 · Cited by 21
Sanjeevi, N., & FREELAND-GRAVES, J. H. (2022) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.13020 · Cited by 20
Cheval, B., Maltagliati, S., Sieber, S., Beran, D., Chalabaëv, A., Sander, D., Cullati, S., & Boisgontier, M. P. (2021) · Annals of Behavioral Medicine · doi:10.1093/abm/kaaa120 · Cited by 22
Intensive Blood Pressure Targets for Diabetic and Other High-Risk Populations
Aggarwal, R., Steinkamp, J., Chiu, N., Petrie, B., & Mirzan, H. (2018) · Hypertension · doi:10.1161/hypertensionaha.117.10713 · Cited by 21
Jin, Y., Xu, Z., Zhang, Y., Zhang, Y., Wang, D., Cheng, Y., Zhou, Y., Fawad, M., & Xu, X. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1280185 · Cited by 21
Liu, J., Pong, A., Gallo, S., Darekar, A., & Terra, S. G. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0856-7 · Cited by 21
Multimorbidity and mortality: A data science perspective
Siah, K. W., Wong, C. H., Gupta, J., & Lo, A. W. (2022) · Journal of Multimorbidity and Comorbidity · doi:10.1177/26335565221105431 · Cited by 22
Dhingra, R., He, F., Al‐Shaar, L., Saunders, E. F. H., Chinchilli, V. M., Yanosky, J. D., & Liao, D. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.12.038 · Cited by 23
Evidence for the Universal Blood Pressure Goal of <130/80 mm Hg Is Strong
Kaul, S. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.14648 · Cited by 20
Marcotte‐Chénard, A., Tremblay, D., Mony, M. M., Brochu, M., Dionne, I. J., Langlois, M., Mampuya, W. M., Morais, J. A., Tessier, D., & Riesco, É. (2021) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2021.102233 · Cited by 21
Association of Socioeconomic Status With Ideal Cardiovascular Health in Black Men
Azap, R. A., Nolan, T. S., Gray, D. M., Lawson, K., Gregory, J. R., Capers, Q., Odei, J. B., & Joseph, J. J. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.020184 · Cited by 21
Evolution of Blood Pressure Clinical Practice Guidelines: A Personal Perspective
Whelton, P. K. (2019) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2019.02.019 · Cited by 21
Diabetes mellitus type 1 in adults
Dedov, I. I., Shestakova, M. V., Mayorov, A. Y., Шамхалова, М. Ш., Nikonova, T. V., Sukhareva, O. Y., Пекарева, Е. В., Ibragimova, L. I., Mikhina, M. S., Galstyan, G. R., et al. (2020) · Diabetes Mellitus · doi:10.14341/dm12505 · Cited by 19
Chen, K., Zhuang, Z., Shao, C., Zheng, J., Zhou, Q., Dong, E., Huang, T., & Tang, Y. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.813208 · Cited by 20
Karamanakos, G., Barmpagianni, A., Kapelios, C. J., Kountouri, A., Bonou, M. S., Makrilakis, K., Lambadiari, V., Barbetseas, J. D., & Liatis, S. (2022) · Primary care diabetes · doi:10.1016/j.pcd.2022.10.003 · Cited by 20
Alhassan, Y., Kwakye, A. O., Dwomoh, A. K., Baah-Nyarkoh, E., Ganu, V. J., Appiah, B., & Kretchy, I. A. (2022) · PLOS Global Public Health · doi:10.1371/journal.pgph.0001342 · Cited by 19
Vora, J. P., Cherney, D. Z. I., Kosiborod, M., Spaak, J., Kanumilli, N., Khunti, K., Lam, C. S. P., Bachmann, M., Fenici, P., & the CaReMe Global Alliance (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15485 · Cited by 26
Sushith, S., Krishnamurthy, H. N., Reshma, S., Dsa, J., Madan, G. R., Ashok, K. J., Prathima, M. B., & Kalal, B. S. (2020) · Reports of Biochemistry and Molecular Biology · doi:10.29252/rbmb.9.2.241 · Cited by 19
Diabetes and cardiovascular disease in older adults
Bilal, A., & Pratley, R. E. (2024) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.15259 · Cited by 18
Sönmez, A., Taşçı, İ., Demirci, İ., Haymana, C., Barçın, C., Aydin, H., Çetinkalp, Ş., Öztürk, F. Y., Gül, K., Sabuncu, T., et al. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00779-0 · Cited by 18
Цукровий діабет і артеріальна гіпертензія
Сергієнко, В. О., & Serhiyenko, O. (2021) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.17.2.2021.230573 · Cited by 27
Eckert, A. J., Zimny, S., Altmeier, M., Dugic, A., Gillessen, A., Bozkurt, L., Götz, G., Karges, W., Wosch, F. J., Kreß, S., et al. (2024) · Journal of Diabetes · doi:10.1111/1753-0407.13531 · Cited by 21
Arrieta, F., Iglesias, P., Pedro‐Botet, J., Becerra, A., Ortega, E., Obaya, J. C., Nubiola, A., Maldonado, G. F., Campos, M. D. M., Petrecca, R., et al. (2018) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2018.03.002 · Cited by 18
Goldberg, T., Brener, A., Levy, S., Interator, H., Laurian, I., Dorfman, A., Chorna, E., Oren, A., Eyal, O., & Lebenthal, Y. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3356 · Cited by 18
Poulsen, M. N., Schwartz, B. S., Nordberg, C. M., DeWalle, J., Pollak, J., Imperatore, G., Mercado, C. I., Siegel, K. R., & Hirsch, A. G. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18020614 · Cited by 18
Screening: terminology, principles and international experience
Drapkina, O. M., & Samorodskaya, I. V. (2019) · Russian Journal of Preventive Medicine · doi:10.17116/profmed20192201190 · Cited by 17
Lu, L., Koo, S., McPherson, S., Hull, M. A., Rees, C. J., & Sharp, L. (2022) · Colorectal Disease · doi:10.1111/codi.16092 · Cited by 17
Diabetic Kidney Disease Prevention Care Model Development
ElSayed, N. A., Bannuru, R. R., Bakris, G. L., Bardsley, J. K., de Boer, I. H., Gabbay, R. A., Gockerman, J. P., McCoy, R. G., McCracken, E., Neumiller, J. J., et al. (2023) · Clinical Diabetes · doi:10.2337/cd23-0063 · Cited by 22
Self-citationNavigating Privacy and Security in Telemedicine for Primary Care
Andreadis, K. (2024) · The American Journal of Managed Care · doi:10.37765/ajmc.2024.89553 · Cited by 19
Pérez‐Pevida, B., Díaz‐Gutiérrez, J., Miras, A. D., Silva, C., Romero, S., Salvador, J., Escalada, J., & Frühbeck, G. (2018) · Obesity · doi:10.1002/oby.22147 · Cited by 17
The Management of Hypertension in 2018: What Should the Targets Be?
Ali, W., & Bakris, G. L. (2019) · Current Hypertension Reports · doi:10.1007/s11906-019-0946-7 · Cited by 17
Self-citation
Metadata
- Authors
- de Boer, I. H., Bangalore, S., Benetos, A., Davis, A. M., Michos, E. D., Muntner, P., Rossing, P., Zoungas, S., & Bakris, G.
- Affiliations
- University of Washington, Seattle, WA
- New York University (US)
- Université de Lorraine, Nancy, France
- University of Chicago (US)
- Johns Hopkins University (US)
- University of Alabama at Birmingham (US)
- University of Copenhagen (DK)
- Monash University (AU)
- Corresponding author
- Bakris, George
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2017-08-14
- Volume
- 40
- Issue
- 9
- Pages
- 1273-1284
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2748201042
- Semantic Scholar
- 4e3c7fd3bbe3119a559b61514192347b33e3e619
- Cited by
- 714
- References
- 145
- Citations by year
- 2026: 30 · 2025: 67 · 2024: 89 · 2023: 69 · 2022: 102 · 2021: 113 · 2020: 83 · 2019: 81 · 2018: 71 · 2017: 5
- FWCI
- 9.25
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- Monash University Research Portal (Monash University) (submittedVersion, other-oa)
- Funders
- Amgen
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- Sanofi
- Ironwood Pharmaceuticals, Incorporated
- Medicines Company
- Steno Diabetes Center Copenhagen (SDCC 3.A Complications)
- Novo Nordisk
- Astellas Pharma
- Novo Nordisk Fonden (NNF14OC0013659)
- Servier
- Sanofi Australia
- Abbott Vascular
- Defense Acquisition Program Administration
- Relypsa
- National Heart, Lung, and Blood Institute
- Cilag
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Keywords
- hypertension, diabetes mellitus, atherosclerotic cardiovascular disease, heart failure, microvascular complications, antihypertensive therapy, blood pressure screening, home blood pressure monitoring, white coat hypertension, orthostatic hypotension, blood pressure control, risk factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
